|
Nanotechnology Colloquium
|
Colloquium Date: Monday, March 3, 2008
|
A bi-weekly event to present and discuss issues related to developments, applications and commercialization of nanotechnology.
Development of Plasma-based Surgical Tools: History, Challenges and Status
Jean Woloszko, MD, PhD.
Vice-President, Chief Technology Officer, ArthroCare
(VIDEO CONFERENCED FROM THE AUSTIN OFFICE OF WINSTEAD PC)
Abstract:
TFounded in 1993, ArthroCare Corp. (www.arthrocare.com) is a highly innovative,
multi-business medical device company that develops, manufactures and markets
minimally invasive surgical products. With these products, ArthroCare targets a
multi-billion dollar market opportunity across several medical specialties,
significantly improving existing surgical procedures and enabling new, minimally
invasive procedures. Over the past 10 years, ArthroCare has experienced a
Compound Annual Growth Rate of 45%.
Many of ArthroCare's products are based on its patented Coblation technology,
which uses radiofrequency to create a low-temperature atmospheric glow discharge
plasma to gently and precisely dissolve rather than burn soft tissue -- minimizing
damage to healthy tissue. Used in more than four million surgeries worldwide, Coblation-based devices have been developed and marketed for sports medicine; spine/neurologic; ear, nose and throat (ENT); cosmetic; urologic and gynecologic procedures.
ArthroCare also has added a number of novel technologies to its portfolio,
including Opus Medical sports medicine, Parallax spine and Applied Therapeutics
ENT products, to complement Coblation within key indications.
Bio: Jean Woloszko, MD, PhD.
Jean Woloszko joined ArthroCare in 1998 as Medical Director and was promoted to
Vice-President Research and Development in 1999 and to his current position in
2003. Prior to joining ArthroCare, he served in various medical, research and
academic positions in Europe and in the US. He also was senior manager of research
and medical affairs at Medtronic.
He holds a Ph.D. in Bioengineering from the University of Illinois, Chicago and
received his medical degree from the Université de Montpellier (France). He also
holds a certification in Rehabilitation Medicine and in Biomechanics. He
authored over 100 patents and 50 scientific publications.
|
|
|
VENUE: You may attend the presentation from any
one of these law offices of Winstead PC or from UT Dallas
|
|
AUSTIN: Winstead PC
401 Congress Av., Ste 2100
Austin, TX 78701
512-370-2800
|
|
COLLEGE STATION: Texas A&M University
Wisenbaker Building (WERC), Room #049,
College Station, TX 77843;
979-845-8912
|
|
DALLAS: The University of Texas at Dallas,
The School of Management,
800 West Campbell Road, Room SOM1.502 map
Richardson, TX 75080; 972-883-4568
|
|
|
HOUSTON: Winstead PC
1100 JPMorgan Chase Tower
600 Travis Street
Houston, TX 77002
713-650-8400
|
|
|
SAN ANTONIO: Winstead PC
700 N. St Mary St., Ste 1900
San Antonio, TX 78205
210-277-6800
|
|
|
THE WOODLANDS: Winstead PC
600 Town Center One
1450 Lake Robbins Drive
The Woodlands, TX 77380
281-681-5900
|
|
|
Program begins at 11:30am with a complimentary lunch provided by Winstead PC.
Presentation begins at 12:00pm.
Event Coordinators:
Richard Fink 512-339-5020x130 dfink@appliednanotech.net
Max Roundhill 512-339-5020x120 roundhill@appliednanotech.net
Chairman: Dr. Zvi Yaniv
Registration deadline is Friday, February 29 at 5:00 PM Central.
To register, please send an email to Deepika Misra
dmisra@winstead.com with your preferred attendance location.
|
| |
|
|
NANOMATERIALS APPLICATION CENTER
Walt Trybula, Ph.D.
Director
Texas State University
San Marcos, TX
(512) 245-6062
|
DVDs of selected presentations from previous
speakers are available for a small fee (contact
Max Roundhill mroundhill@appliednanotech.net)
NanoExpress, a monthly email newsletter, is
devoted to providing information on technological
advances, applications, and business news to
nanotechnology professionals. To subscribe, go to
the web link
http://www.txstate.edu/nac/nanoexpress.htmlx
Return to the Schedule Page
|
|
